Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Europe CRO Companies

ID: MRFR/HC/11110-HCR
128 Pages
Vikita Thakur
Last Updated: April 06, 2026
Contract Research Organizations (CROs) in Europe play a significant role in providing outsourced research services to the pharmaceutical, biotechnology, and medical device industries. This includes preclinical research, clinical trial management, data management, regulatory affairs, pharmacovigilance, and post-marketing surveillance.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Top Industry Leaders in the Europe CRO Market

Europe CRO Key Companies
 
Latest Europe CRO Companies Update

Parexel Acquired US-based Clinical Trials Services by Catalent Pharma Solutions for €1.2 billion, aiming to strengthen its global footprint and capabilities.

ICON Purchased US-based PRA Healthsciences in a $12 billion deal, solidifying its position as a leading global CRO.

BioPharma Services Holding Received a €475 million investment from the Carlyle Group to support its European expansion and clinical development services.

Syneos Health Announced a strategic partnership with the University of Oxford to establish a center for excellence in clinical research and innovation.IQVIA Launched a new AI-powered platform, IQuintain, to optimize clinical trial design and conduct.

List of Europe CRO Key Companies in the Market

  • Pharmaceutical Product Development, LLC (Thermo Fisher Scientific ) (U.S.)
  • Medpace Holdings, Inc. (U.S.)
  • Parexel International Corporation (Ireland)
  • IQVIA (U.S.)
  • Laboratory Corporation of America Holdings (U.S.)
  • Charles River Laboratories (U.S.)
  • PHASTAR (U.K.)
  • Oy 4Pharma Ltd (Finland)
  • PSI (Switzerland)
  • Icon plc (Ireland)